Striatal Medium Spiny Neurons in Huntington's Disease

📖 Wiki Page

cell789 wordssynced 2026-04-02

Striatal Medium Spiny Neurons in Huntington's Disease

<div class="infobox infobox-cell">
<div class="infobox-header">Striatal Medium Spiny Neurons</div>
<div class="infobox-row"><span class="infobox-label">Cell Type</span><span class="infobox-value">GABAergic Projection Neurons</span></div> [@plotkin2020]
<div class="infobox-row"><span class="infobox-label">Location</span><span class="infobox-value">Striatum (caudate nucleus, putamen)</span></div> [@ferrante2021]
<div class="infobox-row"><span class="infobox-label">Neurotransmitter</span><span class="infobox-value">GABA</span></div> [@cepeda2022]
<div class="infobox-row"><span class="infobox-label">Pathology</span><span class="infobox-value">Early degeneration in HD</span></div>
</div>

Pathway / Mechanism Diagram

graph TD A["HTT Gene: CAG Repeat Expansion"] --> B["Mutant Huntingtin (mHTT)"] B --> C["Polyglutamine Aggregation"] C --> D["Nuclear Inclusions"] B --> E["Transcriptional Dysregulation"] E --> F["BDNF Downregulation"] F --> G["Striatal Neuron Vulnerability"] B --> H["Mitochondrial Dysfunction"] H --> I["Energy Deficit"] B --> J["Impaired Autophagy"] J --> K["Toxic Protein Accumulation"] G --> L["Medium Spiny Neuron Death"] I --> L K --> L L --> M["Chorea and Motor Symptoms"] L --> N["Cognitive Decline"] L --> O["Psychiatric Symptoms"] style A fill:#ef5350,color:#e0e0e0 style L fill:#ef5350,color:#e0e0e0 style B fill:#5d4400,color:#e0e0e0

Introduction

...

Striatal Medium Spiny Neurons in Huntington's Disease

Pathway / Mechanism Diagram

Mermaid diagram (expand to render)

Introduction

Striatal medium spiny [neurons](/entities/neurons) (MSNs) are the principal neurons of the striatum, comprising approximately 90-95% of all striatal neurons. These GABAergic projection neurons are the primary effectors of the basal ganglia motor loop, integrating excitatory cortical and thalamic inputs to modulate movement. In Huntington's disease (HD), MSNs are among the first neuronal populations to degenerate, leading to the characteristic choreiform movements, cognitive deficits, and psychiatric symptoms [1](https://doi.org/10.1016/j.tins.2020.08.008).

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:1001474](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474) | medium spiny neuron |

Morphology & Electrophysiology

Morphology: medium spiny neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

External Database Links

[Cell Ontology (CL:1001474)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474)
[OBO Foundry (CL:1001474)](http://purl.obolibrary.org/obo/CL_1001474)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:1001474](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474) | medium spiny neuron | Exact |

External Database Links

[Cell Ontology (CL:1001474)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474)
[OBO Foundry (CL:1001474)](http://purl.obolibrary.org/obo/CL_1001474)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)

Anatomy and Morphology

Structural Characteristics

MSNs possess distinctive morphological features [2](https://doi.org/10.1093/brain/awaa224):

Cell body: 10-20 μm diameter, medium-sized
Dendrites: Highly branched, dense spine coverage (approximately 10,000 spines per neuron)
Axon: Long, myelinated projection to globus pallidus and substantia nigra
Spines: [Dendritic spines](/mechanisms/dendritic-spines) receive ~95% of excitatory synaptic input

Two MSN Subtypes

MSNs are divided into two populations based on projection target and neurochemical phenotype [3](https://doi.org/10.1016/j.neuron.2020.03.012):

| Feature | D1-MSNs (Direct Pathway) | D2-MSNs (Indirect Pathway) |
|---------|--------------------------|----------------------------|
| Dopamine Receptor | D1R | D2R |
| Projection | Substantia nigra pars reticulata (SNr) | Globus pallidus externus (GPe) |
| Effect on Movement | Movement initiation | Movement suppression |
| Pathway | Direct | Indirect |
| Neuropeptide | Dynorphin | Enkephalin |

Molecular Characteristics

Dopamine Receptor Signaling

D1 receptors (DRD1): Gs-coupled, increase cAMP, promote movement
D2 receptors (DRD2): Gi-coupled, decrease cAMP, inhibit movement

Intracellular Signaling Pathways

cAMP/PKA pathway: Regulates neuronal excitability
DARPP-32: Amplifies dopamine signaling
[mTOR](/mechanisms/mtor-signaling-pathway) pathway: Protein synthesis, synaptic plasticity
ERK/MAPK pathway: Gene expression, survival

Marker Genes

DRD1: Direct pathway marker
DRD2: Indirect pathway marker
PENK: Preproenkephalin (D2-MSNs)
PDYN: Prodynorphin (D1-MSNs)
RGS9: Regulator of G-protein signaling

Normal Function

Motor Control

MSNs integrate information to modulate movement [1](https://doi.org/10.1016/j.tins.2020.08.008):

Direct pathway (D1-MSNs): Facilitate movement by inhibiting SNr output

Indirect pathway (D2-MSNs): Suppress competing movements via GPe

Learning and Habit Formation

Reinforcement learning through reward prediction errors
Procedural memory formation
Habit encoding in sensorimotor striatum

Reward Processing

Integrate dopaminergic reward signals
Modulate goal-directed and habitual behaviors

Huntington's Disease Pathology

Early Vulnerability

MSNs are selectively vulnerable in HD due to [2](https://doi.org/10.1093/brain/awaa224):

Direct pathway degeneration: D1-MSNs degenerate first
Indirect pathway involvement: D2-MSNs affected later
Differential vulnerability: Striosomal MSNs more affected than matrix

Mutant Huntingtin (mHTT)

The CAG repeat expansion in the HTT gene produces mutant [huntingtin protein](/proteins/huntingtin):

Polyglutamine expansion: >35 CAG repeats causes disease
Toxic gain-of-function: mHTT forms aggregates
Loss of normal function: Disrupted transcription, transport

Pathological Mechanisms

Transcriptional Dysregulation

mHTT disrupts gene expression [3](https://doi.org/10.1016/j.neuron.2020.03.012):

CREB dysfunction: Impaired transcription
REST dysregulation: Altered neuronal gene expression
PGC-1α suppression: Mitochondrial dysfunction
Reduced neurotrophic factors: BDNF, GDNF

Excitotoxicity

Excessive glutamate signaling:

[NMDA receptor](/entities/nmda-receptor) overactivation: Calcium influx
Metabotropic glutamate receptors: mGluR1/5 signaling
AMPA receptor dysfunction: Altered synaptic transmission

Mitochondrial Dysfunction

PGC-1α deficiency: Impaired biogenesis
Complex I deficiency: Reduced ATP production
Calcium buffering: Impaired mitochondrial calcium handling
Oxidative stress: [ROS](/entities/reactive-oxygen-species) accumulation

Protein Aggregation

mHTT aggregates: Intraneuronal inclusion bodies
[Autophagy](/entities/autophagy) impairment: Defective protein clearance
Ubiquitin-proteasome dysfunction: Reduced degradation

Neuropathological Findings

Striatal atrophy: 50-70% neuron loss in advanced HD
Nuclear inclusions: mHTT in neuronal nuclei
Dendritic spine loss: Reduced synaptic connectivity
Gliosis: Reactive astrocytosis

Therapeutic Implications

Disease-Modifying Strategies

HTT-lowering therapies: ASOs, RNAi, CRISPR
Small molecule inhibitors: Targeting aggregation
Neurotrophic factors: BDNF, GDNF delivery
Cell replacement: Stem cell transplantation

Symptomatic Treatments

Dopamine blockers: Tetrabenazine, deutetrabenazine
Glutamate modulators: Amantadine
Deep brain stimulation: Target STN, GPe
Gene therapy: AAV-based approaches

External Links

[Wikipedia](https://en.wikipedia.org/)
[NCBI Resources](https://www.ncbi.nlm.nih.gov/)

📖 View canonical wiki page →

Striatal Medium Spiny Neurons in Huntington's Disease

Striatal Medium Spiny Neurons in Huntington's Disease

Striatal Medium Spiny Neurons in Huntington's Disease

Pathway / Mechanism Diagram

Introduction

Striatal Medium Spiny Neurons in Huntington's Disease

Striatal Medium Spiny Neurons in Huntington's Disease

Pathway / Mechanism Diagram

Introduction

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

External Database Links

Taxonomy & Classification

External Database Links

Anatomy and Morphology

Structural Characteristics

Two MSN Subtypes

Molecular Characteristics

Dopamine Receptor Signaling

Intracellular Signaling Pathways

Marker Genes

Normal Function

Motor Control

Learning and Habit Formation

Reward Processing

Huntington's Disease Pathology

Early Vulnerability

Mutant Huntingtin (mHTT)

Pathological Mechanisms

Transcriptional Dysregulation

Excitotoxicity

Mitochondrial Dysfunction

Protein Aggregation

Neuropathological Findings

Therapeutic Implications

Disease-Modifying Strategies

Symptomatic Treatments

See Also

External Links